No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

HMRC says 25% of R&D Tax Relief Scheme Disbursements are Unaccounted For

by
July 18, 2023
in Investing
0
HMRC says 25% of R&D Tax Relief Scheme Disbursements are Unaccounted For
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

HM Revenue & Customs has calculated that in the 2020-21 financial year, £1.1 billion was taken due to fraud and mistakes from two separate programs targeting both larger and smaller companies.

The tax authority has acknowledged that a quarter of the funds provided through a multi-billion tax relief program were lost to fraud and mistakes.

HM Revenue & Customs has significantly increased their estimate of losses stemming from error and fraud for research and development tax incentives for small and mid-sized firms from 2020 to 2021, with a shocking figure of 24.4 per cent being calculated — one of the highest rates of loss across any government spending programme, including Covid-19 emergency schemes.

The National Audit Office’s comptroller & auditor-general, Gareth Davies, qualified his opinion of HMRC’s annual accounts when they were published yesterday, due to the issue at hand.

The prediction of Lord Agnew of Oulton was that “no one from the government would be brought to task over this debacle”.

Agnew of Oulton, a past counter-fraud minister, commented: “This instance is another example of the incompetence that pervades the halls of Whitehall.

Justin Arnesen, Partner in the R&D Tax team at Evelyn Partners comments: “R&D tax reliefs are instrumental in encouraging businesses to invest in R&D, which brings broader benefits to the UK economy in the form of developing new products and creating jobs. However, this latest update from HMRC highlights the size of the problem that HMRC is tackling in its attempts to combat fraud and error within the system.  Concern over abuse and boundary-pushing has grown in recent years, and HMRC has introduced a number of measures, including more than doubling the number of people working on R&D compliance and setting up a dedicated R&D Anti-Abuse Unit, to crack-down on unscrupulous advisers and fraudulent and erroneous claims for R&D tax reliefs.

“Improved guidance is part of the wider plan to reduce error and fraud within the R&D regimes, and HMRC has committed to making further improvements as part of its plan. To have an impact, however, considerable changes are required, particularly to guidance around ‘modern/relatable examples’ of both qualifying and non-qualifying activities. This is important as technology is moving at an unprecedented pace – the R&D Guidelines have a qualification example pertaining to the development of a DVD player, for example, this technology is obsolete and provides little relatable guidance/reference points for taxpayers.  Guidance improvements will need to be accompanied by plans to bring HMRC caseworkers up to speed on both the new guidance and the technical qualification criteria.

“To tackle this worrying problem, a range of additional changes have been introduced.  These range from requiring additional information from the claimant and requiring claims to be made digitally, to reducing the amount of payable relief in the SME scheme.  Some of these changes are already in place and others come into effect from August 2023.  Even though HMRC will share a further update on its approach to improving compliance with R&D tax reliefs in winter 2023, given the 2 year time lag on the estimates, we may not know for some time whether these measures have had a meaningful impact.  It may be that additional measures, such as requiring additional information directly from advisers, or an annual adviser audit, will need to be considered.”

Read more:
HMRC says 25% of R&D Tax Relief Scheme Disbursements are Unaccounted For

Previous Post

Top Destinations Revealed for Spectacular October 2023 Annular Eclipse Viewing

Next Post

Edmonton’s C-Tribe x Tech Festival Celebrates the Collision of Creativity and Diversity

Next Post

Edmonton’s C-Tribe x Tech Festival Celebrates the Collision of Creativity and Diversity

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023
What’s Driving the Drop in Overdose Deaths?

What’s Driving the Drop in Overdose Deaths?

0

0

0

0
What’s Driving the Drop in Overdose Deaths?

What’s Driving the Drop in Overdose Deaths?

May 15, 2025

TWC IT Solutions Achieves Triple ISO Certification to Bolster Security Measures for UK Companies

May 15, 2025

CIBSE President Elect for 2025/26 revealed as David Cooper MBE

May 15, 2025

TABB INC. Explains What You Should Know About Pre-Employment Background Checks

May 15, 2025

Recent News

What’s Driving the Drop in Overdose Deaths?

What’s Driving the Drop in Overdose Deaths?

May 15, 2025

TWC IT Solutions Achieves Triple ISO Certification to Bolster Security Measures for UK Companies

May 15, 2025

CIBSE President Elect for 2025/26 revealed as David Cooper MBE

May 15, 2025

TABB INC. Explains What You Should Know About Pre-Employment Background Checks

May 15, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.